ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $158,892 | -12.3% | 27,827 | -29.3% | 0.12% | -17.3% |
| Q3 2023 | $181,074 | -48.5% | 39,364 | -27.7% | 0.14% | -39.8% |
| Q2 2023 | $351,521 | -2.4% | 54,415 | +14.0% | 0.23% | -8.3% |
| Q1 2023 | $359,982 | -27.0% | 47,743 | -2.0% | 0.25% | -38.5% |
| Q4 2022 | $493,000 | +1.4% | 48,693 | -0.9% | 0.41% | -0.5% |
| Q3 2022 | $486,000 | -8.0% | 49,144 | -0.9% | 0.41% | +240.5% |
| Q2 2022 | $528,000 | +59.0% | 49,591 | +45.8% | 0.12% | -46.0% |
| Q1 2022 | $332,000 | -17.6% | 34,013 | +20.8% | 0.22% | -17.6% |
| Q4 2021 | $403,000 | -16.9% | 28,167 | +16.5% | 0.27% | -18.8% |
| Q3 2021 | $485,000 | – | 24,188 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |